Direct-to-consumer advertising and consumer prescription prices

Drug Information Journal

Volumn 30, Issue 1, 1996, Pages 59-65

  Kopp, Steven W ^a  

^a UNIVERSITY OF ARKANSAS   (United States)

Author keywords

Direct to consumer advertising; Dual stage theory; Economic effects; Prices

Indexed keywords

ADVERTIZING; CONSUMER; DRUG COST; HEALTH ECONOMICS; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE PRICING; REVIEW;

EID: 0030038875     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Alperstein NM, Peyrot M. Consumer Awareness of Prescription Drug Advertising. J Advert Res. 1993;33:50-56.
2. Brinberg D, Morris LA. Advertising Prescription Drugs to Consumer. In: Advances in Marketing and Public Policy. PN Bloom, ed. Greenwich, CT: JAI Press; 1987; 1-40.
3. Gilgore LS. A Consideration of Direct-to-Consumer Advertising of Prescription Drugs and Potential Legal Problems with the Brief Summary Requirement: Is the FDA's Regulatory Authority Illusory? Food, Drug, Cos Law J. 1991;46:849-859.
4. Morris LA, Mazis MB, Brinberg D. Risk Disclosures in Televised Prescription Drug Advertising to Consumers. J Pub Pol Market. 1989;8:64-80.
5. Perri, M, Nelson AA. An Exploratory Analysis of Consumer Recognition of Direct-to-Consumer Advertising of Prescription Medications. J Health Care Market. 1987;7:9-17.
6. Perri M, Dickson WM. Consumer Reaction to a Direct-to-Consumer Prescription Drug Advertising Campaign. J Health Care Market. 1988;8: 65-69.
7. Basara LR. Practical Considerations When Evaluating Direct-to-Consumer Advertising as a Marketing Strategy for Prescription Medications. Drug Inf J. 1994;28:461-470.
8. Cohen EP. Direct-to-the-Public Advertisement of Prescription Drugs. New Engl J Med. 1988; 318:373-375.
9. Deutsch CH. The Growing Brouhaha over Drug Ads. The New York Times. 1989; May 14, 1F+.
10. Gladwell M, Farhi P. Drug Firms Offering New Prescription for TV Ads. Washington Post. 1990; January 28, H1, col. 1.
11. Hoff LC. Advertising Prescription Drugs Direct to the Public: What Are the Issues. Vital Speeches Day. 1984;50:573-576.
12. Masson A. Direct-to Consumer Advertising: A Continuing Controversy. Enhancing Consumer Choice: Proceedings of the Second International Conference on Research in the Consumer Interest. RM Mayer, ed., Columbia, Missouri: American Council on Consumer Interests; 1991:159-168.
13. Schrader JT. Controversial Issues Surrounding Direct-to-Consumer Advertisements of Prescription Drugs. Devel Market Sci. 1993;16:570-575.
14. Sheffet MJ, Kopp SW. Advertising Prescription Drugs Directly to the Public: Headache or Relief? J Pub Pol Market. 1990;9:42-61.
15. Weidenbaum M. Are drug prices too high? Pub Inter. 1993;112:84-89.
16. Albion MS. Advertising's Hidden Effects: Manufacturers' Advertising and Retail Pricing. Boston: Auburn House Publishing Company; 1983.
17. Albion MS, Farris PW. Manufacturer Advertising and Retail Gross Margins. Adv Market Pub Pol. 1987;1:107-135.
18. Liebermann Y, Ayal A. A Test of the Advertising Life-Cycle Theory. Inter J Advert. 1985;4:247-250.
19. Steiner RL. Basic Relationships in Consumer Goods Industries. Res Market. 1984;7:165-208.
20. LaRoche M, Rosenblatt J, Wahler L, Bliemel F. Economic Considerations for Dispensing Pharmacists: The Impact of Price-Quality Evaluations Based on Brand Categorization. J Pharm Market Manage. 1986;1:41-60.
21. Pelton LE, Strutton D, Smith MC. Future Pharmacists and Public Initiatives to Control Retail Drug Prices: A Political Economy Framework. Health Market Quart. 1993;10(3/4):241-259.
22. Kolata G. Pharmacists Help Drug Promotions. New York Times. 1994: July 29, A1, col. 1+.
23. Steiner RL, Intrabrand competition - stepchild of antitrust. Antitrust Bull. 1991;36:155-200.